
Drug Benefit Trends
- Drug Benefit Trends Vol 20 No 2
- Volume 20
- Issue 2
Arthritis Prevalence Projected to Reach 25% by 2030
An estimated 46.4 million US adults, or approximately 21% of the adult population, self-reported a physician-diagnosed form of arthritis, which is the leading cause of disability in the United States, according to 2005 data collected by the National Arthritis Data Work group. The work group estimates that by 2030, the number of US adults aged 18 years and older with arthritis or other rheumatic conditions will jump to nearly 67 million (25% of the adult population)-an increase of about 40% (Figure 1).
An estimated 46.4 million US adults, or approximately 21% of the adult population, self-reported a physician-diagnosed form of arthritis, which is the leading cause of disability in the United States, according to 2005 data collected by the National Arthritis Data Workgroup. The workgroup estimates that by 2030, the number of US adults aged 18 years and older with arthritis or other rheumatic conditions will jump to nearly 67 million (25% of the adult population)-an increase of about 40% (
Figure 1. The number of persons with arthritis is expected to reach 67 million in 2030, an increase of 40% from 2005. Source: Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States, part I and part II. Arthritis Rheum. 2008;58:15-35.
About 27 million US adults have osteoarthritis, one of the most common forms of arthritis, an increase from the 1995 estimate of 21 million adults (
Figure 2. The incidence of osteoarthritis and gout increased significantly between 1995 and 2005, while that of rheumatoid arthritis declined in part because of more restrictive classification criteria. Source: Helmick CG et al. Arthritis Rheum. 2008;58:15-35.
The workgroup also estimated the 2005 incidence of other rheumatic conditions. An estimated 5 million US adults have fibromyalgia, and between 4 million and 10 million US adults have carpal tunnel syndrome.
Although the workgroup did not study costs, direct and indirect costs attributed to arthritis were $127.6 billion in 2003, up from $86.2 billion in 1997 (
Figure 3. Medical expenditures for arthritis are rising more rapidly than indirect costs (lost earnings). Source: Centers for Disease Control and Prevention. National and state medical expenditures and lost earnings attributed to arthritis and other rheumatic conditions-United States, 2003. MMWR. 2007;56:4-7.
An estimated 8.8% of US adults, or nearly 19 million, self-reported arthritis-attributable activity limitations in 2005. This outcome is projected to increase to 9.3% of US adults (25 million) by 2030.
Articles in this issue
over 17 years ago
Mortality Rates for Heart Disease, Stroke Declineover 17 years ago
Food for Thoughtover 17 years ago
Exercising Away Depressionover 17 years ago
The Future of Inhaled Insulin Therapyover 17 years ago
Defining Preventive Care Under CDHPsover 17 years ago
Medicare Prescription Drug Coverageover 17 years ago
Medicare Part D Fuels Growth in Drug SpendNewsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.


























































































































































































































































































